News
Cervical cancer, cancer that we can eliminate
A study of the IDIBELL and ICO team on infections and cancer, in collaboration with WHO and UNICEF, has analyzed the rate of vaccinations around the world. They found that, while there is still a long way and many challenges ahead, there are a few countries that have already achieved it. Therefore it is an acceptable goal.
Xavier Bosch: “If a person has doubts about whether they should be vaccinated, what we have to do is resolve these doubts”
We spoke with Dr. Xavier Bosch, principal investigator of the IDIBELL infection and cancer research group, doctor at the ICO, professor at the UOC, and expert in the vaccine against HPV (human papillomavirus), on the challenge of large-scale vaccination against COVID-19 and the reticence that this whole process is generating.
IDIBELL’s STARS GAME kicks off, an innovative and inquiry-based initiative to transfer scientific research
During the project, a digital escape room will be co-created in coordination with teachers, students, researchers, and science communicators.
Digital health for Bone Marrow Transplantation follow-up: A Pilot Study in times of COVID19
A study from IDIBELL and ICO has shown that telehealth systems can be applied to detect early complications after a bone marrow transplant, both physical and psychological.
85% of the pharmacies in the Metropolitan Region of Barcelona participate in the Colon and Rectal Cancer Early Detection Program
According to a study carried out by researchers from the EPIBELL Program of IDIBELL and the Cancer Screening Unit of ICO Hospitalet, in the period from 2017 to 2018, among 643 pharmacies affiliated with the Official College of Pharmacists, 528 were members of the Program, which corresponds to 85.4% of the total.
Women in science: the 4th sLHam of women scientist of IDIBELL arrives
To commemorate the International Day of Women and Girls in Science, IDIBELL organizes an event where 8 women will explain through an informative talk their work in research and innovation.
![Unitat de Cures Intensives Cardiològiques de l'Hospital de Bellvitge [imatge d'arxiu]](https://idibell.cat/en/wp-content/uploads/sites/2/bb-plugin/cache/Unitat-de-Cures-Intensives-Cardiologiques-de-lHospital-de-Bellvitge-imatge-darxiu-panorama-c37eea1d5dbab9e1eaa363a22be9a09a-.jpg "Unitat de Cures Intensives Cardiològiques de l'Hospital de Bellvitge [imatge d'arxiu]")
Artificial intelligence helps predict relapse of patients recovered from a heart attack or angina
The algorithm, based on data from about 20,000 patients, will facilitate the choice of the best therapeutic option to avoid new episodes of heart failure
A universal weakness of solid tumors opens the door to cancer treatment improvement
The study led by ICO and IDIBELL and UCSF describes, thanks to Big Data analysis, a control mechanism for DNA repair that would sensitize tumors to therapy.
A new study deciphers the mechanisms involved in antitumor activity after inhibition of ribosome synthesis
A research group from IDIBELL has published in the journal Blood their discoveries about the cellular mechanisms responsible for stopping tumor growth by blocking the formation of new ribosomes.